• Tianjin TEDA Biomedical Engineering will hold an extraordinary general meeting in Beijing on Sept. 24, 2026.
• Shareholders will vote on amending the articles to let the board issue new shares of up to 50% within three years.
• The changes would also allow updates to registered capital or issued share count in the articles without another shareholder vote.
• A separate resolution would authorize a director to finalize the amendments and handle related filings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin TEDA Biomedical Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260907-12323371), on September 07, 2026, and is solely responsible for the information contained therein.